Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$3.02 - $4.05 $39,175 - $52,536
12,972 New
12,972 $39,000
Q1 2023

May 15, 2023

BUY
$3.14 - $8.22 $55,242 - $144,614
17,593 Added 22.75%
94,914 $301,000
Q4 2022

Feb 14, 2023

BUY
$5.77 - $8.49 $446,142 - $656,455
77,321 New
77,321 $535,000
Q2 2022

Aug 15, 2022

SELL
$2.94 - $5.23 $256,662 - $456,579
-87,300 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$18.04 - $22.09 $1.42 Million - $1.74 Million
78,801 Added 927.18%
87,300 $2.79 Million
Q1 2021

May 17, 2021

SELL
$16.59 - $33.89 $182 - $372
-11 Reduced 0.13%
8,499 $256,000
Q4 2020

Feb 03, 2021

SELL
$27.5 - $37.92 $9,625 - $13,272
-350 Reduced 3.95%
8,510 $368,000
Q3 2020

Nov 16, 2020

BUY
$34.44 - $43.75 $12,742 - $16,187
370 Added 4.36%
8,860 $478,000
Q2 2020

Aug 12, 2020

SELL
$27.12 - $45.97 $1.07 Million - $1.81 Million
-39,427 Reduced 82.28%
8,490 $518,000
Q1 2020

May 06, 2020

SELL
$26.16 - $63.5 $8,632 - $20,955
-330 Reduced 0.68%
47,917 $2.2 Million
Q4 2019

Feb 14, 2020

BUY
$46.96 - $61.67 $981,323 - $1.29 Million
20,897 Added 76.41%
48,247 $4.23 Million
Q3 2019

Nov 12, 2019

SELL
$59.47 - $93.1 $3,508 - $5,492
-59 Reduced 0.22%
27,350 $2.51 Million
Q2 2019

Aug 14, 2019

BUY
$75.84 - $105.21 $524,585 - $727,737
6,917 Added 33.75%
27,409 $3.49 Million
Q1 2019

May 13, 2019

BUY
$64.44 - $104.11 $303,383 - $490,149
4,708 Added 29.83%
20,492 $3.22 Million
Q3 2018

Nov 14, 2018

BUY
$88.86 - $117.49 $528,717 - $699,065
5,950 Added 60.5%
15,784 $2.3 Million
Q2 2018

Aug 03, 2018

SELL
$99.64 - $127.59 $3.93 Million - $5.03 Million
-39,436 Reduced 80.04%
9,834 $1.54 Million
Q1 2018

May 07, 2018

BUY
$105.8 - $150.94 $554,180 - $790,623
5,238 Added 11.9%
49,270 $8.41 Million
Q3 2017

Nov 01, 2017

BUY
$57.74 - $91.42 $2.54 Million - $4.03 Million
44,032
44,032 $6.05 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.